An external quality assessment program for von Willebrand factor laboratory analysis: An overview from the European Concerted Action on Thrombosis and Disabilities Foundation

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 5, 2006, Pages 485-491

  Meijer, Piet ^a,b   Haverkate, Frits ^a  

^a Foundation of the European Concerted Action on Thrombophilia (ECAT)   (Netherlands)

^b ECAT Foundation   (Netherlands)

Author keywords

Quality control program; Von Willebrand disease; Von Willebrand factor; Von Willebrand factor activity; Von Willebrand factor antigen

Indexed keywords

COLLAGEN; RISTOCETIN; VON WILLEBRAND FACTOR;

ARTICLE; BINDING ASSAY; BIOASSAY; COLLAGEN BINDING ASSAY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXTERNAL QUALITY ASSESSMENT PROGRAM; HUMAN; LABORATORY TEST; LATEX AGGLUTINATION TEST; NON PROFIT ORGANIZATION; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; RISTOCETIN COFACTOR ACTIVITY ASSAY; VON WILLEBRAND DISEASE;

DISABLED PERSONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMANS; LABORATORIES; LABORATORY TECHNIQUES AND PROCEDURES; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; REFERENCE VALUES; THROMBOSIS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33746644201     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947862     Document Type: Article

References (18)

1. Rodeghiero F, Castaman GC, Dini E. Epidemiological investigation of the prevelance of von Willebrand's disease. Blood 1987;69:454-459
2. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893-898
3. Sadler JE, Mannucci PM, Berntop E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-174
4. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71:520-525
5. Favaloro EJ. Appropriate laboratory assessment as a critical facet in the proper diagnosis and subclassification of von Willebrand's disorder. Best Pract Res Clin Haematol 2001;14:299-319
6. Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thomb Hemost 2002;28:173-189
7. Schneppenheim R, Budde U. Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update. Semin Hematol 2005;42:15-28
8. Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J. Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thromb Haemost 1999;82:1276-1282
9. Favaloro EJ, Thomb J, Baker R. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results form the second Australian multilaboratory survey. Blood Coagul Fibrinolysis 2000;11:729-737
10. Favaloro EJ, Bonar R, Sioufi J, et al. Laboratory diagnosis of von Willebrand disorder: current practice in the southern hemisphere. Am J Clin Pathol 2003;119:882-893
11. Favaloro EJ, Bonar R, Kershaw G, et al. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process. Haemophilia 2004;10:232-242
12. Favaloro EJ, Bonar R, Kershaw G, et al. Laboratory diagnosis of von Willebrand disorder: Use of multiple functional assays reduces diagnostic error rates. Lab Hematol 2005;11:91-97
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i(8476):307-310
14. Casonato A, Pontara E, Bertomoro A, Sartorello F, Cattini MG, Girolami A. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin cofactor activity? Br J Haematol 2001;112:578-583
15. Favaloro EJ. A duplex issue: (i) time to re-appraise the diagnosis and classification of von Willebrand disorder (VWD), and (ii) clarification of the roles of von Willebrand factor (WVF) collagen binding and ristocetin cofactor activity assays. Haemophilia 2002;8:828-831
16. Favaloro EJ, Aboud M, Arthur C. Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of-rheumatoid factor. Am J Hematol 2001;66:53-56
17. Meijer P, De Maat MPM, Kluft C, Haverkate F, Van Houwelingen HC. Assessment of the long-term analytical performance of field methods in haemostasis by evaluation of results of an external quality assessment programme. Clin Chem 2002;48:1011-1015
18. Meijer P, Kluft C, Haverkate F, De Maat MPM. The longterm within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT foundation. J Thromb Haemost 2003;1:748-753